BID | 10.52 | ASK | 11.30 | ||
Open | 11.29 | Previous Close | 11.05 | ||
Pre-Market | - | After-Market | 11.17 | ||
- - | 0.06 0.54% |
Target Price | 29.17 | Analyst Rating | Strong Buy 1.44 | |
Potential % | 162.56 | Finscreener Ranking | — - | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★★★ 55.28 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★+ 54.17 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 3.68 | Earnings Rating | — | |
Market Cap | 4.51B | Earnings Date | 2nd Nov 2023 | |
Alpha | -0.02 | Standard Deviation | 0.18 | |
Beta | 0.45 |
Today's Price Range 11.0211.37 | 52W Range 10.4129.44 |
Summary:
Sell
Technical Indicators: | Sell |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | 4.61% | ||
1 Month | -18.73% | ||
3 Months | -40.14% | ||
6 Months | -45.88% | ||
1 Year | -37.85% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -9.65 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -6.01 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -9.00 | |||
Return on invested Capital Q | -2.61 | |||
Return on invested Capital Y | -4.81 | |||
Assets Turnover | 0.50 | |||
Receivables Turnover | 2.10 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-62.30 | ||||
5.84 | ||||
3.58 | ||||
- | ||||
-60.50 | ||||
-0.32 | ||||
6.44 | ||||
2.64 | ||||
5.43B | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.40 | ||||
2.50 | ||||
0.04 | ||||
0.05 | ||||
-28.30 | ||||
Leverage Ratio | 1.70 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
4.40 | ||||
-4.20 | ||||
-3.60 | ||||
- | ||||
-2.49 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.02B | ||||
4.90 | ||||
- | ||||
- |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2023 | -0.05 | -0.06 | -20.00 |
Q02 2023 | -0.01 | -0.04 | -300.00 |
Q01 2023 | 0.03 | 0.04 | 33.33 |
Q04 2022 | -0.08 | -0.14 | -75.00 |
Q03 2022 | -0.05 | -0.07 | -40.00 |
Q02 2022 | -0.02 | -0.04 | -100.00 |
Q01 2022 | 0.00 | 0.00 | - |
Q04 2021 | -0.12 | -0.14 | -16.67 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | - |
Estimated EPS Next Report | -0.05 |
Estimates Count | 8 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 2.49M |
Shares Outstanding | 406.04K |
Shares Float | 301.59M |
Trades Count | 19.93K |
Dollar Volume | 27.71M |
Avg. Volume | 3.69M |
Avg. Weekly Volume | 4.29M |
Avg. Monthly Volume | 3.89M |
Avg. Quarterly Volume | 2.89M |
agilon health inc. (NYSE: AGL) stock closed at 11.11 per share at the end of the most recent trading day (a 0.54% change compared to the prior day closing price) with a volume of 2.49M shares and market capitalization of 4.51B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 552 people. agilon health inc. CEO is Steven J. Sell.
The one-year performance of agilon health inc. stock is -37.85%, while year-to-date (YTD) performance is -31.16%. AGL stock has a five-year performance of %. Its 52-week range is between 10.41 and 29.44, which gives AGL stock a 52-week price range ratio of 3.68%
agilon health inc. currently has a PE ratio of -62.30, a price-to-book (PB) ratio of 5.84, a price-to-sale (PS) ratio of 3.58, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -6.01%, a ROC of -9.00% and a ROE of -9.65%. The company’s profit margin is -2.49%, its EBITDA margin is -3.60%, and its revenue ttm is $2.02 Billion , which makes it $4.90 revenue per share.
Of the last four earnings reports from agilon health inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.05 for the next earnings report. agilon health inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for agilon health inc. is Strong Buy (1.44), with a target price of $29.17, which is +162.56% compared to the current price. The earnings rating for agilon health inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
agilon health inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
agilon health inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 51.76, ATR14 : 0.74, CCI20 : -61.95, Chaikin Money Flow : -0.26, MACD : -1.28, Money Flow Index : 31.84, ROC : -6.95, RSI : 34.50, STOCH (14,3) : 33.82, STOCH RSI : 0.88, UO : 40.00, Williams %R : -66.18), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of agilon health inc. in the last 12-months were: Benjamin Kornitzer (Option Excercise at a value of $1 641 478), Benjamin Kornitzer (Sold 189 909 shares of value $4 351 602 ), Benjamin Shaker (Option Excercise at a value of $657 500), Benjamin Shaker (Sold 297 500 shares of value $6 853 600 ), Desai Veeral (Sold 0 shares of value $-570 000 ), Desai Veeral (Sold 190 000 shares of value $5 274 941 ), Gertsch Timothy (Option Excercise at a value of $196 700), John William Wulf (Option Excercise at a value of $720 000), John William Wulf (Sold 160 000 shares of value $3 810 824 ), Schwaneke Jeffrey (Buy at a value of $250 206), Sell Steven (Buy at a value of $497 847), Shaker Benjamin (Option Excercise at a value of $1 262 038), Shaker Benjamin (Sold 422 500 shares of value $9 400 088 ), Veeral Desai (Option Excercise at a value of $556 500), Veeral Desai (Sold 185 500 shares of value $5 157 103 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
CEO: Steven J. Sell
Telephone: +1 562 256-3800
Address: 1 World Trade Center, Long Beach 90831, CA, US
Number of employees: 552
Mon, 13 Nov 2023 10:41 GMT Analysts Conflicted on These Healthcare Names: Zimmer Biomet Holdings (ZBH), Agilon Health (AGL) and Aeglea Biotherapeutics (AGLE)
- TipRanks. All rights reserved.Mon, 14 Aug 2023 13:01 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Agilon Health (AGL), BeiGene (BGNE) and Trevi Therapeutics (TRVI)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.